8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 8 of 8 clinical reviews.
A clinical and journalistic breakdown of what peptide protocols Andrew Huberman likely uses, whether compounded or branded options fit his public statements, and what the science actually shows.
A clinical breakdown of Andrew Huberman's publicly discussed peptide stack, the published evidence behind each compound, and how outcomes for general patients compare to what Huberman reports.
A clinical look at how Andrew Huberman's public discussion of peptide stacks, BPC-157, TB-500, and related compounds has driven telehealth demand, and what the evidence actually supports.
A journalistic and clinical breakdown of how Andrew Huberman's public discussion of peptide stacks moved from mainstream acceptance to regulatory scrutiny, and what the science actually says.
A clinical and journalistic review of Andrew Huberman's peptide discussions, covering FDA regulatory status, FTC influencer disclosure rules, and the published evidence behind BPC-157, TB-500, and related compounds.
A clinical and journalistic analysis of Andrew Huberman's reported peptide protocols, with photographic before/after context, mechanism-of-action breakdowns, and primary-source citations on BPC-157, TB-500, and related compounds.
A clinical and journalistic breakdown of the peptide protocols Andrew Huberman has discussed publicly, the private-clinic process behind them, and what the peer-reviewed evidence actually says about BPC-157, TB-500, CJC-1295, and more.
A clinical breakdown of Andrew Huberman's peptide stack, what compounded peptides actually cost for a celebrity vs. A regular telehealth patient, and what the evidence says about BPC-157, TB-500, and growth hormone secretagogues.